A detailed history of State Street Corp transactions in Ardelyx, Inc. stock. As of the latest transaction made, State Street Corp holds 11,965,061 shares of ARDX stock, worth $76.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,965,061
Previous 14,089,026 15.08%
Holding current value
$76.9 Million
Previous $103 Million 13.79%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.89 - $9.31 $12.5 Million - $19.8 Million
-2,123,965 Reduced 15.08%
11,965,061 $88.7 Million
Q1 2024

May 15, 2024

SELL
$6.05 - $9.74 $18.2 Million - $29.4 Million
-3,013,572 Reduced 17.62%
14,089,026 $103 Million
Q4 2023

Feb 14, 2024

BUY
$3.29 - $6.64 $13.1 Million - $26.4 Million
3,976,602 Added 30.3%
17,102,598 $106 Million
Q3 2023

Nov 14, 2023

SELL
$3.3 - $4.83 $30.7 Million - $45 Million
-9,311,568 Reduced 41.5%
13,125,996 $53.6 Million
Q2 2023

Aug 14, 2023

BUY
$3.23 - $4.95 $23.4 Million - $35.8 Million
7,234,448 Added 47.59%
22,437,564 $76.1 Million
Q1 2023

May 15, 2023

BUY
$2.68 - $4.79 $39 Million - $69.7 Million
14,549,803 Added 2227.08%
15,203,116 $72.8 Million
Q4 2022

Feb 14, 2023

BUY
$1.22 - $2.85 $300,608 - $702,240
246,400 Added 60.55%
653,313 $1.86 Million
Q3 2022

Nov 15, 2022

SELL
$0.59 - $1.44 $43,778 - $106,848
-74,200 Reduced 15.42%
406,913 $484,000
Q2 2022

Aug 15, 2022

SELL
$0.51 - $1.17 $839,686 - $1.93 Million
-1,646,444 Reduced 77.39%
481,113 $284,000
Q1 2022

May 16, 2022

BUY
$0.65 - $1.18 $90,664 - $164,591
139,484 Added 7.02%
2,127,557 $2.28 Million
Q4 2021

Feb 14, 2022

SELL
$0.86 - $1.7 $25,434 - $50,277
-29,575 Reduced 1.47%
1,988,073 $2.19 Million
Q3 2021

Nov 15, 2021

SELL
$1.27 - $8.17 $5.41 Million - $34.8 Million
-4,263,149 Reduced 67.88%
2,017,648 $2.66 Million
Q2 2021

Aug 16, 2021

BUY
$6.55 - $8.98 $16.5 Million - $22.6 Million
2,515,575 Added 66.81%
6,280,797 $47.6 Million
Q1 2021

May 17, 2021

BUY
$6.1 - $7.69 $8.13 Million - $10.2 Million
1,332,556 Added 54.78%
3,765,222 $24.9 Million
Q4 2020

Feb 16, 2021

SELL
$5.05 - $7.1 $1.25 Million - $1.75 Million
-246,795 Reduced 9.21%
2,432,666 $15.7 Million
Q3 2020

Nov 10, 2020

SELL
$5.25 - $7.08 $2.01 Million - $2.71 Million
-382,089 Reduced 12.48%
2,679,461 $14.1 Million
Q2 2020

Aug 14, 2020

BUY
$5.37 - $8.11 $10.3 Million - $15.5 Million
1,908,921 Added 165.61%
3,061,550 $21.2 Million
Q1 2020

May 11, 2020

BUY
$4.35 - $8.79 $5.01 Million - $10.1 Million
1,152,629 New
1,152,629 $6.55 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $994M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.